Clinical Trials Directory

Trials / Conditions / Head and Neck Squamous Cell Carcinomas

Head and Neck Squamous Cell Carcinomas

7 registered clinical trials studyying Head and Neck Squamous Cell Carcinomas — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other S
NCT06469008
Sichuan Baili Pharmaceutical Co., Ltd.Phase 1
Not Yet RecruitingMyeloprotection With Trilaciclib in Pan-cancer Population
NCT06297811
Sun Yat-sen UniversityPhase 2
Active Not RecruitingNeoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)
NCT05724329
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
UnknownNeoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcino
NCT06235918
Xiang LuPhase 2
RecruitingTislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Nec
NCT05582265
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3
TerminatedPF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
NCT05233436
PfizerPhase 1
RecruitingA Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
NCT04992559
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2